Literature DB >> 1332920

Clearance of HBsAg in seven patients with chronic hepatitis B.

H Adachi1, S Kaneko, E Matsushita, Y Inagaki, M Unoura, K Kobayashi.   

Abstract

The natural history of chronic hepatitis B patients who spontaneously cleared serum HBsAg was investigated. A total of 351 patients with chronic hepatitis B were observed in our hospital for at least 3 yr. Seven of these patients became HBsAg negative during the follow-up period. HBsAg disappeared within 6 mo (range = 11 to 169 days, mean = 70 days) after acute elevation of ALT. ALT levels as high as 500 IU were found in three patients, whereas such elevation was not demonstrated in the other four patients. After the disappearance of HBsAg, ALT levels returned to normal in all patients. With one exception, all patients seroconverted to antibody to HBsAg; however, hepatitis B virus DNA remained detectable in serum using the polymerase chain reaction in five patients. The titer of percent inhibition of antibody to HBcAg gradually decreased to less than 70% when a 1:200 dilution of the serum of six patients was used. Four of the patients had active liver disease develop: two had chronic active hepatitis and two had cirrhosis. Three of these four patients subsequently had hepatocellular carcinoma develop. These findings suggest that patients may suffer complications of chronic hepatitis even after normalization of transaminase activities and after the clearance of HBsAg. Thus hepatitis B virus should be considered as a possible factor associated with hepatocellular carcinoma even in the absence of HBsAg, particularly if serum hepatitis B virus DNA persists.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1332920     DOI: 10.1002/hep.1840160605

Source DB:  PubMed          Journal:  Hepatology        ISSN: 0270-9139            Impact factor:   17.425


  8 in total

Review 1.  Diagnosis and management of clinical and subclinical cobalamin deficiency: advances and controversies.

Authors:  Ralph Carmel; Mona Sarrai
Journal:  Curr Hematol Rep       Date:  2006-03

2.  Hepatocellular carcinoma (HCC) recurring 10 years after clearance of hepatitis B surface antigen and 20 years after resection of hepatitis B virus-related HCC.

Authors:  Hiroji Shinkawa; Takuya Nakai; Akihiro Tamori; Hiromu Tanaka; Shigekazu Takemura; Kazuki Ohba; Takahiro Uenishi; Masao Ogawa; Satoshi Yamamoto; Seikan Hai; Tsuyoshi Ichikawa; Shintaro Kodai; Kazuhiro Hirohashi; Kenichi Wakasa; Shoji Kubo
Journal:  Int J Clin Oncol       Date:  2008-12-18       Impact factor: 3.402

3.  Spontaneous hepatitis B surface antigen clearance in a long-term follow-up study of patients with chronic type B hepatitis. Lack of correlation with hepatitis C and D virus superinfection.

Authors:  L C Da Silva; C L Madruga; F J Carrilho; J R Pinho; A Saéz-Alquezar; C Santos; L Bassit; C Barreto; L E Fonseca; V A Alves; R Leitão; R Vianna; R A Cardoso; A V França; L C Gayotto
Journal:  J Gastroenterol       Date:  1996-10       Impact factor: 7.527

4.  Lower hepatitis G virus infection prevalence compared to hepatitis B and C virus infection prevalences.

Authors:  N Furusyo; J Hayashi; I Ariyama; Y Sawayama; Y Etoh; S Kashiwagi
Journal:  Dig Dis Sci       Date:  2000-01       Impact factor: 3.199

5.  Remote development of hepatocellular carcinoma in patients with liver cirrhosis type B serologically cured for HBs antigenemia with long-standing normalization of ALT values.

Authors:  Shogo Okoshi; Masato Igarashi; Takeshi Suda; Hiroshi Iwamatsu; Kohji Watanabe; Kiyoshi Ishihara; Norio Ogata; Minoru Nomoto; Toru Takahashi; Takafumi Ichida; Hitoshi Asakura; Koei Nihei; Isao Kurosaki
Journal:  Dig Dis Sci       Date:  2002-09       Impact factor: 3.199

6.  Hepatitis B virus persistence after recovery from acute viral hepatitis.

Authors:  T I Michalak; C Pasquinelli; S Guilhot; F V Chisari
Journal:  J Clin Invest       Date:  1994-01       Impact factor: 14.808

Review 7.  Hepatitis B virus and its sexually transmitted infection - an update.

Authors:  Takako Inoue; Yasuhito Tanaka
Journal:  Microb Cell       Date:  2016-09-05

8.  Time to seroconversion of HBsAg to anti-HBs in individuals who lost HBsAg during follow-up.

Authors:  M R H Roushan; M Mohammadpour; M Baiany; S Soleimani; A Bijani
Journal:  Epidemiol Infect       Date:  2016-06-08       Impact factor: 4.434

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.